Dr. M-J Milloy, Ph.D., Research Scientist with the British Columbia Centre on Substance Use at the British Columbia Centre for Excellence in HIV/AIDS.
Dr. Milloy offers a scientific rationale to evaluate the use of cannabis/cannabinoids to reduce the harms of opioid and stimulant dependence in the context of the North American overdose crisis.
He conducted this presentation at “the Inaugural Symposium on Cannabis and People Living with HIV: At the Crossroads Between Neuropsychology and Inflammation.” On April 5, 2019, it took place at the MUHC Glen site Research Institute.
The CIHR Canadian HIV Trials Network (CTN) has, since 1990, been supporting a thriving community of researchers, people living with HIV and their caregivers, health advocates, and pharmaceutical and biotechnology companies to generate knowledge about prevention, treatment, management, and a cure for HIV/AIDS and other blood-borne and sexually transmitted infections. Learn more, http://hivnet.ubc.ca.
Subscribe to our channel! http://bit.ly/2XpUdJM
Follow our social media platforms:
Facebook: CIHR Canadian HIV Trials Network – CTN
Linkedin: CIHR Canadian HIV Trials Network